| Schedule of restatement on the balance sheets, statements of operations and statements of cash flows |
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of |
|
|
|
|
|
|
|
|
|
October 22, 2019 |
|
As Reported |
|
Adjustment |
|
As Restated |
Warrant Liabilities |
|
$ |
— |
|
$ |
1,356,300 |
|
$ |
1,356,300 |
Total Liabilities |
|
|
82,127 |
|
|
1,356,300 |
|
|
1,438,427 |
Ordinary shares subject to redemption |
|
|
133,895,920 |
|
|
(1,356,300) |
|
|
132,539,620 |
Ordinary Shares |
|
|
401 |
|
|
14 |
|
|
415 |
Additional paid-in capital |
|
$ |
5,052,511 |
|
$ |
4,064 |
|
$ |
5,056,575 |
Retained earnings (Accumulated deficit) |
|
|
(52,908) |
|
|
(4,078) |
|
|
(56,986) |
Total Shareholders’ Equity |
|
$ |
5,000,004 |
|
$ |
— |
|
$ |
5,000,004 |
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption |
|
|
13,389,592 |
|
|
(135,630) |
|
|
13,253,962 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of |
|
|
|
|
|
|
|
|
|
December 31, 2019 |
|
As Reported |
|
Adjustment |
|
As Restated |
Warrant Liabilities |
|
$ |
— |
|
$ |
1,972,800 |
|
$ |
1,972,800 |
Total Liabilities |
|
|
65,716 |
|
|
1,972,800 |
|
|
2,038,516 |
Ordinary shares subject to redemption |
|
|
134,190,490 |
|
|
(1,972,800) |
|
|
132,217,690 |
Ordinary Shares |
|
|
398 |
|
|
20 |
|
|
418 |
Additional paid-in capital |
|
$ |
4,757,944 |
|
$ |
620,558 |
|
$ |
5,378,502 |
Retained earnings (Accumulated deficit) |
|
$ |
241,659 |
|
$ |
(620,578) |
|
$ |
(378,919) |
Total Shareholders’ Equity |
|
$ |
5,000,001 |
|
$ |
— |
|
$ |
5,000,001 |
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption |
|
|
13,419,049 |
|
|
(197,280) |
|
|
13,221,769 |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
|
|
|
|
|
period from July 30, 2019 (inception) to December 31, 2019 |
|
As Reported |
|
Adjustment |
|
As Restated |
Transaction costs allocable to warrant liabilities |
|
$ |
— |
|
$ |
(4,078) |
|
$ |
(4,078) |
Change in fair value of warrant liabilities |
|
|
— |
|
|
(616,500) |
|
|
(616,500) |
Net income |
|
$ |
241,659 |
|
$ |
(620,578) |
|
$ |
(378,919) |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.05) |
|
$ |
(0.17) |
|
$ |
(0.22) |
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the |
|
|
|
|
Period |
|
|
|
year ended December 31, 2019 |
|
As Reported |
|
|
Adjustment |
|
As Restated |
Net income (loss) |
|
$ |
241,659 |
|
$ |
(620,578) |
|
$ |
(378,919) |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
616,500 |
|
$ |
616,500 |
Transaction costs allocable to warrant liabilities |
|
$ |
— |
|
$ |
4,078 |
|
$ |
4,078 |
Initial classification of warrant liabilities |
|
$ |
— |
|
$ |
1,356,300 |
|
$ |
1,356,300 |
Initial classification of ordinary shares subject to redemption |
|
$ |
133,895,920 |
|
$ |
(1,356,300) |
|
$ |
132,539,620 |
Change in value of ordinary shares subject to possible redemption |
|
$ |
294,570 |
|
$ |
(616,500) |
|
$ |
(321,930) |
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of |
|
|
|
|
Period |
|
|
|
March 31, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Warrant Liabilities |
|
$ |
— |
|
$ |
1,027,500 |
|
$ |
1,027,500 |
Total Liabilities |
|
|
53,215 |
|
|
1,027,500 |
|
|
1,080,715 |
Ordinary shares subject to redemption |
|
|
134,537,080 |
|
|
(1,027,500) |
|
|
133,509,580 |
Ordinary Shares |
|
|
395 |
|
|
10 |
|
|
405 |
Additional paid-in capital |
|
$ |
4,411,357 |
|
$ |
(324,732) |
|
$ |
4,086,625 |
Retained earnings |
|
$ |
588,253 |
|
$ |
324,722 |
|
$ |
912,975 |
Total Shareholders’ Equity |
|
$ |
5,000,005 |
|
$ |
— |
|
$ |
5,000,005 |
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption |
|
|
13,453,708 |
|
|
(102,750) |
|
|
13,350,958 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of |
|
|
|
|
Period |
|
|
|
June 30, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Warrant Liabilities |
|
$ |
— |
|
$ |
2,383,800 |
|
$ |
2,383,800 |
Total Liabilities |
|
|
16,366 |
|
|
2,383,800 |
|
|
2,400,166 |
Ordinary shares subject to redemption |
|
|
134,591,590 |
|
|
(2,383,800) |
|
|
132,207,790 |
Ordinary Shares |
|
|
394 |
|
|
24 |
|
|
418 |
Additional paid-in capital |
|
$ |
4,356,848 |
|
$ |
1,031,554 |
|
$ |
5,388,402 |
Retained earnings (Accumulated deficit) |
|
$ |
642,765 |
|
$ |
(1,031,578) |
|
$ |
(388,813) |
Total Shareholders’ Equity |
|
$ |
5,000,007 |
|
$ |
— |
|
$ |
5,000,007 |
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption |
|
|
13,459,159 |
|
|
(238,380) |
|
|
13,220,779 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of |
|
|
|
|
Period |
|
|
|
September 30, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Warrant Liabilities |
|
$ |
— |
|
$ |
2,548,200 |
|
$ |
2,548,200 |
Total Liabilities |
|
|
15,147 |
|
|
2,548,200 |
|
|
2,563,347 |
Ordinary shares subject to redemption |
|
|
134,531,290 |
|
|
(2,548,200) |
|
|
131,983,090 |
Ordinary Shares |
|
|
395 |
|
|
25 |
|
|
420 |
Additional paid-in capital |
|
$ |
4,417,147 |
|
$ |
1,195,953 |
|
$ |
5,613,100 |
Retained earnings (Accumulated deficit) |
|
$ |
582,459 |
|
$ |
(1,195,978) |
|
$ |
(613,519) |
Total Shareholders’ Equity |
|
$ |
5,000,001 |
|
$ |
0 |
|
$ |
5,000,001 |
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption |
|
|
13,453,129 |
|
|
(254,820) |
|
|
13,198,309 |
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of |
|
|
|
|
Period |
|
|
|
December 31, 2020 |
|
As Reported |
|
Adjustment |
|
As Restated |
Warrant Liabilities |
|
$ |
— |
|
$ |
3,452,400 |
|
$ |
3,452,400 |
Total Liabilities |
|
|
709,732 |
|
|
3,452,400 |
|
|
4,162,132 |
Ordinary shares subject to redemption |
|
|
134,138,890 |
|
|
(3,452,400) |
|
|
130,686,490 |
Ordinary Shares |
|
|
399 |
|
|
34 |
|
|
433 |
Additional paid-in capital |
|
$ |
4,809,543 |
|
$ |
2,100,144 |
|
$ |
6,909,687 |
Retained earnings (Accumulated deficit) |
|
$ |
190,067 |
|
$ |
(2,100,178) |
|
$ |
(1,910,111) |
Total Shareholders’ Equity |
|
$ |
5,000,009 |
|
$ |
— |
|
$ |
5,000,009 |
|
|
|
|
|
|
|
|
|
|
Number of shares subject to possible redemption |
|
|
13,413,889 |
|
|
(345,240) |
|
|
13,068,649 |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
Period |
|
|
|
three months ended March 31, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
945,300 |
|
$ |
945,300 |
Net income |
|
$ |
346,594 |
|
$ |
945,300 |
|
$ |
1,291,894 |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.06) |
|
$ |
0.27 |
|
$ |
0.21 |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
Period |
|
|
|
six months ended June 30, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
(411,000) |
|
$ |
(411,000) |
Net income |
|
$ |
401,106 |
|
$ |
(411,000) |
|
$ |
(9,894) |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.08) |
|
$ |
(0.11) |
|
$ |
(0.19) |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
Period |
|
|
three months ended June 30, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
(1,356,300) |
|
$ |
(1,356,300) |
Net income |
|
$ |
54,512 |
|
$ |
(1,356,300) |
|
$ |
(1,301,788) |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.02) |
|
$ |
(0.38) |
|
$ |
(0.40) |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
Period |
|
|
|
nine months ended September 30, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
(575,400) |
|
$ |
(575,400) |
Net income (loss) |
|
$ |
340,800 |
|
$ |
(575,400) |
|
$ |
(234,600) |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.10) |
|
$ |
(0.16) |
|
$ |
(0.26) |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
Period |
|
|
|
three months ended September 30, 2020 (unaudited) |
|
As Reported |
|
Adjustment |
|
As Restated |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
(164,400) |
|
$ |
(164,400) |
Net income (loss) |
|
$ |
(60,306) |
|
$ |
(164,400) |
|
$ |
(224,706) |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.30) |
|
$ |
0.23 |
|
$ |
(0.07) |
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the |
|
|
|
|
Period |
|
|
|
year ended December 31, 2020 |
|
As Reported |
|
Adjustment |
|
As Restated |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
(1,479,600) |
|
$ |
(1,479,600) |
Net income (loss) |
|
$ |
(51,592) |
|
$ |
(1,479,600) |
|
$ |
(1,531,192) |
Basic and diluted net loss per ordinary share, non-redeemable |
|
$ |
(0.22) |
|
$ |
(0.41) |
|
$ |
(0.63) |
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the |
|
|
|
|
|
|
|
|
|
period ended March 31, 2020 (unaudited) |
|
As Reported |
|
Period Adjustment |
|
As Restated |
Net income (loss) |
|
$ |
346,594 |
|
$ |
945,300 |
|
$ |
1,291,894 |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
(945,300) |
|
$ |
(945,300) |
Change in value of ordinary shares subject to possible redemption |
|
$ |
346,590 |
|
$ |
945,300 |
|
$ |
1,291,890 |
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the |
|
|
|
|
|
|
|
|
|
period ended June 30, 2020 (unaudited) |
|
As Reported |
|
Period Adjustment |
|
As Restated |
Net income (loss) |
|
$ |
401,106 |
|
$ |
(411,000) |
|
$ |
(9,894) |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
411,000 |
|
$ |
411,000 |
Change in value of ordinary shares subject to possible redemption |
|
$ |
401,100 |
|
$ |
(411,000) |
|
$ |
(9,900) |
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the |
|
|
|
|
|
|
|
|
|
period ended September 30, 2020 (unaudited) |
|
As Reported |
|
Period Adjustment |
|
As Restated |
Net income (loss) |
|
$ |
340,800 |
|
$ |
(575,400) |
|
$ |
(234,600) |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
575,400 |
|
$ |
575,400 |
Change in value of ordinary shares subject to possible redemption |
|
$ |
340,800 |
|
$ |
(575,400) |
|
$ |
(234,600) |
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows for the |
|
|
|
|
|
|
|
|
|
year ended December 31, 2020 |
|
As Reported |
|
Period Adjustment |
|
As Restated |
Net income (loss) |
|
$ |
(51,592) |
|
$ |
(1,479,600) |
|
$ |
(1,531,192) |
Change in fair value of warrant liabilities |
|
$ |
— |
|
$ |
1,479,600 |
|
$ |
1,479,600 |
Change in value of ordinary shares subject to possible redemption |
|
$ |
(51,600) |
|
$ |
(1,479,600) |
|
$ |
(1,531,200) |
|